# Topotecan in Glioma Undergoing A Clinically-Indicated Surgical Resection

> **NCT02500459** · EARLY_PHASE1 · TERMINATED · sponsor: **Michael Vogelbaum, MD, PhD** · enrollment: 9 (actual)

## Conditions studied

- Brain Tumor
- High Grade Glioma

## Interventions

- **DRUG:** topotecan
- **DEVICE:** Cleveland Multiport Catheter

## Key facts

- **NCT ID:** NCT02500459
- **Lead sponsor:** Michael Vogelbaum, MD, PhD
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-07-06
- **Primary completion:** 2018-11-19
- **Final completion:** 2018-11-19
- **Target enrollment:** 9 (ACTUAL)
- **Why stopped:** PI Left institution
- **Last updated:** 2019-03-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02500459

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02500459, "Topotecan in Glioma Undergoing A Clinically-Indicated Surgical Resection". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02500459. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*